33 Essential Tremor Clinical Trials in Birmingham, AL (2026)

Q: Are there essential tremor clinical trials in Birmingham?

Yes, there are 33 essential tremor clinical trials currently recruiting in Birmingham, AL.

Q: How do I join a clinical trial in Birmingham?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Birmingham research site will contact you.

Q: Are clinical trials in Birmingham free?

Yes, clinical trial participation is always free. Study-related treatments, medical tests, and doctor visits are provided at no cost.

Recruiting Essential Tremor Studies in Birmingham

NCT02474160Recruiting

Collection and Storage of Tissue and Blood Samples From Patients With Cancer

This study collects and stores tissue and blood samples from patients with cancer. Collecting and storing samples of tissue and blood from patients with cancer to study in the laboratory may help scie...

Birmingham, AL5,000 participantsNational Cancer Institute LAO

View Study Details

NCT06525259Recruiting

DISCOVERY of Risk Factors for Type 2 Diabetes in Youth

The goal of the DISCOVERY study is to provide innovative critical information regarding the unique natural history of glycemic control, insulin sensitivity, and β-cell function, and their mechanistic ...

Birmingham, AL3,600 participantsGeorge Washington University

View Study Details

NCT06980025Recruiting

Aspirin Dose Escalation for the Prevention of Recurrent Preterm Delivery Trial

This is a phase-III multi-center double-blind randomized clinical trial of 1,800 individuals with a history of prior preterm birth at less than 35 weeks gestation who are randomized to either 162 mg a...

Birmingham, ALPHASE31,800 participantsThe George Washington University Biostatistics Center

View Study Details

NCT03538665Recruiting

The DETECT Study: Discovery and Evaluation of Testing for Endometrial and Ovarian Cancer in Tampons

BACKGROUND: Endometrial cancer is a common and deadly cancer for women. It is getting more common and deadly because risk factors like age and obesity are increasing. Also, this cancer is becoming mo...

Birmingham, AL1,500 participantsUniversity of Alabama at Birmingham

View Study Details

NCT06628908Recruiting

Evaluation of Efficacy and Safety of Suzetrigine for Pain Associated With Diabetic Peripheral Neuropathy

The purpose of this study is to evaluate the efficacy, safety, and tolerability of Suzetrigine (SUZ) in participants with pain associated with diabetic peripheral neuropathy (DPN)....

Birmingham, ALPHASE31,100 participantsVertex Pharmaceuticals Incorporated

View Study Details

NCT07231419Recruiting

Evaluation of Efficacy and Safety of Suzetrigine (SUZ) for Pain Associated With Diabetic Peripheral Neuropathy

The purpose of this study is to evaluate the efficacy, safety, and tolerability of Suzetrigine in participants with pain associated with diabetic peripheral neuropathy (DPN)....

Birmingham, ALPHASE3734 participantsVertex Pharmaceuticals Incorporated

View Study Details

NCT06701903Recruiting

Study of ITI-1284 as Monotherapy Treatment in Patients With Generalized Anxiety Disorder

This is a multicenter, randomized, double-blind, placebo-controlled study to assess the efficacy, safety, and tolerability of ITI-1284 as monotherapy treatment in patients meeting Diagnostic and Stati...

Birmingham, ALPHASE2570 participantsIntra-Cellular Therapies, Inc.

View Study Details

NCT06628453Recruiting

CGM for Management of Type 2 Diabetes in Pregnancy

The goal of this clinical trial is to learn if continuous glucose monitoring works better than self-monitoring of blood glucose (fingersticks) to treat type 2 diabetes in pregnancy. It will also learn...

Birmingham, ALNA564 participantsUniversity of Alabama at Birmingham

View Study Details

NCT06893939Recruiting

Limited Versus Extended Trophic Feeding (LET-FEED) Trial

Study Hypothesis/Question In infants born very preterm, advancing enteral feeds after 24 hours from birth (limited trophic feeds) versus after 72 hours (extended trophic feeds) reduces the risk of all...

Birmingham, ALPHASE3350 participantsUniversity of Washington

View Study Details

NCT07335497Recruiting

CR-001 in Adult Participants With Locally Advanced or Metastatic Solid Tumors

The purpose of this study is to determine the safety and tolerability of monotherapy CR-001 and identify the maximum tolerated dose (MTD), and/or optimal biologic dose and Recommended Phase 2 Dose(s) ...

Birmingham, ALPHASE1290 participantsCrescent Biopharma, Inc.

View Study Details

NCT07198074Recruiting

Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer

This phase III trial compares the effect of bevacizumab in combination with carboplatin, paclitaxel and pembrolizumab to the usual treatments of carboplatin and paclitaxel with or without pembrolizuma...

Birmingham, ALPHASE3255 participantsNational Cancer Institute (NCI)

View Study Details

NCT04031677Recruiting

Surgery With or Without Neoadjuvant Chemotherapy in High Risk RetroPeritoneal Sarcoma

This is a multicenter, randomized, open label phase lll trial to assess whether preoperative chemotherapy, as an adjunct to curative-intent surgery, improves the prognosis of high risk DDLPS (dediffer...

Birmingham, ALPHASE3250 participantsEuropean Organisation for Research and Treatment of Cancer - EORTC

View Study Details

NCT07340320Recruiting

A Study of CX11 Tablets in Patients With Type 2 Diabetes Mellitus

This study is testing whether a new medication called CX11 works and is safe for participants with type 2 diabetes who have not reached good blood sugar control while taking a steady dose of metformin...

Birmingham, ALPHASE2240 participantsCorxel Pharmaceuticals

View Study Details

NCT06099769Recruiting

A Study of Enzalutamide, Enzalutamide in Combination With Mifepristone, or Chemotherapy in People With Metastatic Breast Cancer

The researchers are doing this study to find out if the study drug, enzalutamide, alone or combined with the study drug, mifepristone, is effective in treating advanced or metastatic androgen receptor...

Birmingham, ALPHASE2201 participantsMemorial Sloan Kettering Cancer Center

View Study Details

NCT05762107Recruiting

A Study of the Effect of ZT-01 on Night-time Hypoglycemia in Type 1 Diabetes

The goal of this clinical trial is to learn about the effect of the study drug (ZT-01) on low blood sugar (hypoglycemia) in adults with type 1 diabetes (T1D) who have been having low blood sugars ("hy...

Birmingham, ALPHASE2186 participantsZucara Therapeutics Inc.

View Study Details

NCT07190300Recruiting

TulmiSTAR-02: A Phase I/II Open-label Study of Tulmimetostat in Combination With Darolutamide vs. Darolutamide, and Tulmimetostat With Abiraterone in Patients With Metastatic Hormone-sensitive Prostate Cancer (mHSPC)

The purpose of the study is to evaluate the safety, tolerability, and efficacy of the two different treatment combinations of tulmimetostat in participants with de novo or recurrent Metastatic Hormone...

Birmingham, ALPHASE1181 participantsNovartis Pharmaceuticals

View Study Details

NCT04462770Recruiting

A Study of EPX-100 (Clemizole Hydrochloride) in Participants With Dravet Syndrome

This is a multicenter, Phase 3, randomized, double-blind, placebo-controlled study designed to evaluate the efficacy and safety of clemizole hydrochloride (EPX-100) as adjunctive therapy in children a...

Birmingham, ALPHASE3150 participantsEpygenix

View Study Details

NCT07285018Recruiting

A Chronic Pain Master Protocol (CPMP): A Study of LY4065967 in Participants With Diabetic Peripheral Neuropathic Pain

The purpose of this study is to test the safety and efficacy of study drug LY4065967 for the treatment of diabetic peripheral neuropathic pain (DPNP). This trial is part of the chronic pain master pro...

Birmingham, ALPHASE2150 participantsEli Lilly and Company

View Study Details

NCT05606432Recruiting

Cardiometabolic Health Intervention Using Movement-to-Music Exercise

The study aims to test the benefits of a 24-week, cardio-emphasized Movement-to-Music exercise program for reversing cardiometabolic health risk factors compared to asynchronous, standard exercise pro...

Birmingham, ALNA132 participantsUniversity of Alabama at Birmingham

View Study Details

NCT07143968Recruiting

A Study to Evaluate the Use of Resmetirom in Participants With MASLD and HIV

The purpose of this research study is to test the safety and effectiveness of the study drug, resmetirom, in participants with MASLD and HIV. This is a research study to test a drug that is already on...

Birmingham, ALPHASE2120 participantsNaga P. Chalasani

View Study Details

NCT03403686Recruiting

Liver X Receptor (LXR) as a Novel Therapeutic Target in Diabetic Retinopathy (DR)

Results from large clinical trials demonstrate a strong association between lipid abnormalities and progression of the most common microvascular complication, diabetic retinopathy (DR). We found that ...

Birmingham, AL104 participantsUniversity of Alabama at Birmingham

View Study Details

NCT05112601Recruiting

Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma

This phase II trial tests whether the combination of nivolumab and ipilimumab is better than nivolumab alone to shrink tumors in patients with deficient mismatch repair system (dMMR) endometrial carci...

Birmingham, ALPHASE281 participantsNational Cancer Institute (NCI)

View Study Details

NCT07502508Recruiting

Phase 2 Trial of Icovamenib in Participants With Type 2 Diabetes Mellitus Who Are Not Achieving Glycemic Targets While Using GLP-1-Based Therapy

This is a phase 2 randomized, double-blind, placebo-controlled trial assessing the efficacy and safety of icovamenib in participants with Type 2 Diabetes (T2D) not achieving glycemic targets despite O...

Birmingham, ALPHASE260 participantsBiomea Fusion Inc.

View Study Details

NCT06491537Recruiting

Time-restricted Eating for Postpartum Weight Loss

This study is being done to assess the feasibility and acceptability of a time-restricted eating intervention among postpartum women with overweight/obesity....

Birmingham, ALNA60 participantsUniversity of Alabama at Birmingham

View Study Details

NCT06524960Recruiting

Denosumab for Type 1 Diabetes

Type 1 diabetes (T1D) arises from abnormal immune cell-mediated injury to beta cells that make insulin. The injured beta cells can then no longer make the needed amount of insulin to stay healthy. How...

Birmingham, ALPHASE145 participantsCity of Hope Medical Center

View Study Details

NCT07288008Recruiting

Transcranial Alternating Current Stimulation (tACS) for the Treatment of Anxiety in Veterans: An Open-Label Pilot Study

Transcranial alternating current stimulation (tACS) in a wearable brain stimulation device that delivers a low intensity, pulsed, alternating current via scalp electrodes. Prior sham-controlled clinic...

Birmingham, ALNA40 participantsBirmingham VA Health Care System

View Study Details

NCT06902077Recruiting

A Low-Carb Approach to Treat Type 2 Diabetes in Pediatric Patients

The purpose of this project is to test the effect of a low carb diet compared to standard carb diet among adolescents with T2D over a 24-week period....

Birmingham, ALNA40 participantsUniversity of Alabama at Birmingham

View Study Details

NCT06714864Recruiting

Open-Label Study to Assess Safety and Time to Catheter-related Bloodstream Infections (CRBSI) in Subjects From Birth to < 18 Years of Age

This study is a post-marketing approval requirement to assess the safety and time to Catheter-related Bloodstream Infections (CRBSI) of DefenCath in pediatric population (birth to less than 18 years o...

Birmingham, ALPHASE436 participantsCorMedix

View Study Details

NCT05504291Recruiting

A Study to Give Treatment Inside the Eye to Treat Retinoblastoma

This phase II trial tests the safety and side effects of adding melphalan (by injecting it into the eye) to standard chemotherapy in early treatment of patients with retinoblastoma (RB). RB is a type ...

Birmingham, ALPHASE226 participantsChildren's Oncology Group

View Study Details

NCT03403699Recruiting

Human iPSC for Repair of Vasodegenerative Vessels in Diabetic Retinopathy

This study proposes to carefully examine the hypothesis that human inducible pluripotent stem cells (iPSCs) can be effectively employed as a future therapeutic option for individuals with diabetic ret...

Birmingham, AL20 participantsUniversity of Alabama at Birmingham

View Study Details

NCT06771206Recruiting

Evaluation of Accuracy of the Owlet OSS 3.0 Sensor in the Neonatal Population

The sponsor of this study, Owlet Baby Care, Inc., is comparing the accuracy of their pulse oximeter Sensor with the measurements of oxygen levels in newborns who are already being monitored with arter...

Birmingham, ALNA20 participantsOwlet Baby Care, Inc.

View Study Details

NCT07546409Recruiting

Effects of Exogenous Ketones on Cognitive Function in Older Adults With Prediabetes?

Brief Summary The goal of this clinical trial is to learn whether older adults with prediabetes, but no diagnosed cognitive impairment, show early changes in brain energy use and thinking speed compa...

Birmingham, ALNA20 participantsUniversity of Alabama at Birmingham

View Study Details

NCT07194044Recruiting

Metastatic Ewing's Trial Testing Schedule Enhancement to Improve Outcomes

This single arm study is designed to demonstrate the feasibility of a radically different approach for an exceptionally high-risk subset of MES with widely metastatic disease (WMES). We incorporate th...

Birmingham, ALPHASE115 participantsH. Lee Moffitt Cancer Center and Research Institute

View Study Details

About Essential Tremor Clinical Trials in Birmingham

Essential tremor is one of the most common movement disorders, causing involuntary shaking, most often in the hands. It is different from Parkinson's disease, though the two can be confused. Treatment includes medications, focused ultrasound, and deep brain stimulation for severe cases.

There are currently 33 essential tremor clinical trials recruiting participants in Birmingham, AL. These studies are seeking a combined 17,940 participants. Research is being sponsored by National Cancer Institute LAO, George Washington University, The George Washington University Biostatistics Center and 21 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Essential Tremor Clinical Trials in Birmingham — FAQ

Are there essential tremor clinical trials in Birmingham?

Yes, there are 33 essential tremor clinical trials currently recruiting in Birmingham, AL. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Birmingham?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Birmingham research site will contact you about next steps.

Are clinical trials in Birmingham free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Birmingham studies also compensate for your time and travel.

What essential tremor treatments are being tested?

The 33 active trials in Birmingham are testing new therapies including novel drugs, biologics, and treatment approaches for essential tremor.

Data updated July 17, 2026 from ClinicalTrials.gov